Overview

Extended Therapeutic Effect of 35kDa Hyaluronan Fragment Injection in Patients With Chronic Pain Caused by Myofascial Pain Syndrome

Status:
ENROLLING_BY_INVITATION
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
To verify the efficacy and safety of HA35 in chronic pain management and to further supplement effective treatments for chronic pain, we designed a proof-of-concept clinical study. This study aims to evaluate the 15-day treatment of HA35 on patients with myofascial pain syndrome and to observe the effects for up to 3 months.
Phase:
NA
Details
Lead Sponsor:
Nakhia Impex LLC